Can we safely skip a Pre-Transplant bile duct scan? a trial tests the limits of simpler donor checks

NCT ID NCT07715500

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This trial studies whether omitting a routine magnetic resonance cholangiopancreatography (MRCP) scan in healthy living liver donors affects the rate of bile duct complications in transplant recipients. About 100 donors aged 18–55 will be randomly assigned to receive or skip the MRCP before surgery. The goal is to see if the scan is truly necessary for safe surgical planning or if intraoperative assessment alone is sufficient.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Magnetic Resonance Cholangiopancreatography (MRCP) scan
What this could lead to
If skipping routine MRCP before liver donation proves safe, it could simplify donor evaluation and reduce healthcare costs without harming transplant outcomes.
What could go wrong
This is a single-center trial with 100 participants, so results may not apply broadly. The study is designed to test non-inferiority, not superiority, and missing a subtle bile duct variation could still increase recipient complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LIVER DISEASE AND CIRRHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

Locations

  • ILBS

    RECRUITING

    New Delhi, 110070, India

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.